Structure via PubChem · Public domain (PubChem)
DMMDA
Sign in to saveAlso known as 1-(4,7-dimethoxy-1,3-benzodioxol-5-yl)propan-2-amine, 2,5-dimethoxy-3,4-methylenedioxyamphetamine, 1-(4,7-dimethoxy-2H-1,3-benzodioxol-5-yl)propan-2-amine
2,5-Dimethoxy-3,4-methylenedioxyamphetamine (DMMDA or DMMDA-1) is a lesser-known psychedelic drug of the amphetamine and MDxx families related to MMDA. It was first synthesized by Alexander Shulgin in the 1960s and was described in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved).
Chemical data
- Formula
- C12H17NO4
- Molecular weight
- 239.27 g/mol
- IUPAC name
- 1-(4,7-dimethoxy-1,3-benzodioxol-5-yl)propan-2-amine
via PubChem
Drug data · ChEMBL
- Molecule type
- Small molecule
via ChEMBL · EBI
~8 min read
Encyclopedic overview
18 sectionsContents
- Use and effects
- Interactions
- Pharmacology
- Pharmacodynamics
- Chemistry
- Isomers and enantiomers
- Synthesis
- Shulgin's synthesis
- Other synthetic methods
- General synthetic information
- History
- Society and culture
- Legal status
- Canada
- United States
- See also
- References
- External links
2,5-Dimethoxy-3,4-methylenedioxyamphetamine (DMMDA or DMMDA-1) is a lesser-known psychedelic drug of the amphetamine and MDxx families related to MMDA. It was first synthesized by Alexander Shulgin in the 1960s and was described in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved).
==Use and effects== Alexander Shulgin listed the dose of DMMDA in his book PiHKAL (Phenethylamines I Have Known and Loved) as 30 to 75mg orally and the duration as 6 to 8hours. He reported DMMDA as producing LSD-like subjective effects: images, mydriasis, ataxia, and time dilation. DMMDA is not mentioned much in literature outside PiHKAL.
Excerpted from Wikipedia’s “DMMDA” article, available under the CC BY-SA 4.0 licence.